Evidence map›Paper›PMID 19627450›Full record

ArticleJournal of neurochemistry2009

Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.

Irit Rappley, David S Myers, Stephen B Milne, Pavlina T Ivanova, Matthew J Lavoie, H Alex Brown, Dennis J Selkoe

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Parkinson disease is a fatty acidopathy.Nature reviews. Neurology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Effect of Heavy IonMolecules (Basel, Switzerland) · 2020
    Article
  13. Article
  14. Article
  15. The Role of Lipids in the Initiation of α-Synuclein Misfolding.Frontiers in cell and developmental biology · 2020
    Review
  16. Review
  17. Review
  18. Age-Related Changes in the Gut Microbiota Modify Brain Lipid Composition.Frontiers in cellular and infection microbiology · 2019
    Article
  19. Effects of the LPAFrontiers in molecular neuroscience · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Irit RappleyCenter for Neurologic Diseases, Harvard Medical School and Brigham & Women's Hospital, Boston, Massachusetts, USA.
David S Myers
Stephen B Milne
Pavlina T Ivanova
Matthew J Lavoie
H Alex Brown
Dennis J Selkoe
Vanderbilt University Medical Center · USBrigham and Women's Hospital · US

Funding

STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
The chemical genetics of PD: a high throughput drug screening programP50NS038375 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI STEIN, ROSS L · 1999 to 2009
$14.9M
Alpha-Synuclein, PUFA and Membrane Vesicles in Health and Parkinson's DiseaseR01NS051318 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SELKOE, DENNIS J · 2006 to 2010
$1.5M
NIGMS NIH HHS U54 GM069338NINDS NIH HHS P50 NS038375NINDS NIH HHS R01 NS051318
6 · The paper itself

Abstract

Advances in lipidomics technology have facilitated the precise detection, identification and profiling of lipid species within tissues. Mass spectrometry allows for identification of lipids as a function of the total number of carbons and double bonds in their acyl chains. Such detailed descriptions of lipid composition can provide a basis for further investigation of cell signaling and metabolic pathways, both physiological and pathological. Here, we applied phospholipid profiling to mouse models relevant to Parkinson's disease, using mice that were transgenic for human alpha-synuclein (alphaSyn) or deleted of endogenous alphaSyn. Proposed functions of alphaSyn include phospholipid binding, regulation of membrane composition, and regulation of vesicular pools. We investigated whether alphaSyn gene dosage interacts with differences in phospholipid composition across brain regions or with age-related changes in brain phospholipid composition. The most dramatic phospholipid changes were observed in alphaSyn wild-type animals as a function of age and gender. alphaSyn genotype-specific changes were also observed in aged, but not young, mice. Our results provide a detailed and systematic characterization of brain phospholipid composition in mice and identify age-related changes relevant both to Parkinson's disease and to normal aging.

Indexed as

MetabolomeAge Factorsalpha-SynucleinAnalysis of VarianceAnimalsBrainFemaleGene DosageGlycerophospholipidsHumansMaleMass SpectrometryMiceMice, Inbred DBAMice, TransgenicPrincipal Component Analysisalpha-SynucleinGlycerophospholipids

Identifiers

PMID19627450
PMCPMC2752313
OpenAlexW1986527452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.